Cargando…

Natural toll-like receptor agonists in prophylactic vaccines for dendritic cell activation

Detalles Bibliográficos
Autores principales:	Peng, Paul, Hammerich, Linda, Brody, Joshua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652518/ http://dx.doi.org/10.1186/2051-1426-3-S2-P446

Ejemplares similares

Differential modulation of cysteinyl leukotriene receptor 1 and 2 expression by distinct Toll-like receptor agonists in monocyte-derived dendritic cells
por: Rola-Pleszczynski, M, et al.
Publicado: (2004)

Induction of hypoxia inducible factor 1α by Toll-like receptors in human dendritic cells
por: Djafarzadeh, S, et al.
Publicado: (2008)

Toll-like receptor 4 polymorphisms and ankylosing spondylitis
por: Adam, R, et al.
Publicado: (2005)

Toll-like receptor expression in synovial fibroblasts and normal skin fibroblasts and induction of matrix metallo-proteinase expression by various Toll-like receptor ligands
por: Kyburz, D, et al.
Publicado: (2005)

Toll-Like Receptors are critical in controlling colonic inflammation and cancer
por: Xiao, Hui, et al.
Publicado: (2011)

Toll-like receptor ligands regulate the migratory pattern of leukocytes
por: Nieto, J C, et al.
Publicado: (2010)

Toll like receptor 1 polymorphisms and susceptibility to invasive candidiasis
por: Plantinga, T, et al.
Publicado: (2009)

Differential Toll-like receptor-dependent collagenase expression in chondrocytes
por: Zhang, Qian, et al.
Publicado: (2007)

Potent induction of antibody-secreting B-cells by human dermal-derived CD14+ dendritic cells triggered by dual toll-like receptor ligation
por: Matthews, K, et al.
Publicado: (2012)

P10-02. Toll-like receptor activation profiles of wild-type, recombinant, and mutant Lactobacillus: implications for vaccine design
por: Stoeker, L, et al.
Publicado: (2009)

Proteomic analysis of Systemic Sclerosis serum identifies the toll-like receptor agonists S100A8/A9 as a novel possible pathogenic marker
por: van Bon, L, et al.
Publicado: (2010)

The toll-like receptor 4 agonist MRP8/14 protein complex (calprotectin) in autoinflammation: potential biomarker in chronic nonbacterial osteomyelitis – a case report
por: Brunner, Juergen
Publicado: (2014)

Activation of Dendritic Cells by the Novel Toll-Like Receptor 3 Agonist RGC100
por: Naumann, Kai, et al.
Publicado: (2013)

Local Toll-like receptor-mediated mast cell activation inhibits melanoma growth
por: Oldford, SA, et al.
Publicado: (2010)

Toll-like receptor 9 agonists and IL-15 promote activation, proliferation, secretion of proinflammatory cytokines and differentiation of B cells isolated from bone marrow of rheumatoid arthritis patients
por: Rudnicka, W, et al.
Publicado: (2007)

Regulation of neutrophil chemotaxis by toll-like receptor 9 is important for sepsis survival
por: Trevelin, SC, et al.
Publicado: (2010)

Perivascular adipocytes and signaling through toll-like receptors: role in the pathophysiology of atherosclerosis
por: Benaiges, C, et al.
Publicado: (2010)

The expression and function of toll-like receptors (TLRs) in ovarian cancer cell lines
por: Lee, Shin-Wha, et al.
Publicado: (2015)

Downregulation of IL-6 and preserved reactive oxygen species production in human monocytes tolerized by lipopolysaccharide and challenged with Toll-like receptor agonists and whole Gram-negative and Gram-positive bacteria
por: Fernandes, Maria da Luz, et al.
Publicado: (2008)

Toll-like receptor 4 in phagocytosis of Escherichia coli by endotoxin-activated human neutrophils in whole blood
por: Prokhorenko, I, et al.
Publicado: (2012)

Selective inhibition of Toll-like receptor 4 signaling by the small molecule TAK-242
por: Kawamoto, T, et al.
Publicado: (2006)

Toll-like receptor 9-dependent gene expression in vivo is regulated by inductive and suppressive networks
por: Klaschik, S, et al.
Publicado: (2009)

SNPS in the exons of toll-like receptors are associated with susceptibility to type 1 diabetes in Chinese population
por: Zhi, Dijing, et al.
Publicado: (2015)

Precise determination of toll-like receptor (TLR) 7 expression in multiple human tumor types
por: Cumberbatch, Marie, et al.
Publicado: (2014)

Toll like receptor 2 is overexpressed in FMF patients during attacks and inhibited by colchicine treatment
por: Ben-David, H, et al.
Publicado: (2015)

Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity
por: Vo, Manh-Cuong, et al.
Publicado: (2015)

Toll-like receptor 2 induces chemokine receptor CXCR2 downregulation and neutrophil migration impairment in severe sepsis
por: Alves-Filho, JC, et al.
Publicado: (2007)

Efficiency of Interferon-γ in Activating Dendritic Cells and Its Potential Synergy with Toll-like Receptor Agonists
por: Bian, Yuanzhi, et al.
Publicado: (2023)

Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
por: Chakraborty, Samik, et al.
Publicado: (2023)

Chronic exposure to Interleukin-6 amplifies the response to Toll-like receptor ligands: implication on the pathogenesis of macrophage activation syndrome
por: Strippoli, Raffaele, et al.
Publicado: (2011)

Toll-like receptor dependent autoantigens in animal models and humans in use to improve collagen induced arthritis
por: Marklein, B, et al.
Publicado: (2010)

Toll Like receptor 7 regulates viral loads and cytokine secretion during acute retroviral infection
por: Browne, E
Publicado: (2012)

Expression of Toll-like receptor (TLR) 2, TLR3, TLR4 and TLR7 is increased in rheumatoid arthritis synovium and regulates cytokine production by dendritic cells upon stimulation of TLR specific pathways
por: Roelofs, MF, et al.
Publicado: (2005)

Activation of Toll-like receptor-2 by tumor associated matrix metalloproteinase-2 modulates dendritic cell function
por: Godefroy, Emmanuelle, et al.
Publicado: (2014)

Toll-Like Receptor 9 Agonists in Cancer
por: Karapetyan, Lilit, et al.
Publicado: (2020)

Neutrophil extracellular trap-mediated activation of endosomal toll-like receptors induce immune activation in juvenile-onset systemic lupus erythematosus
por: Makuloluwa, Kanchani K, et al.
Publicado: (2014)

Functional Toll-like receptor 9 modulates the activity of bone marrow B cells isolated from rheumatoid arthritis patients
por: Rudnicka, W, et al.
Publicado: (2005)

IL-1-driven cartilage and bone destruction are dependent on Toll-like receptor (TLR) 4, but not TLR2
por: Abdollahi-Roodsaz, S, et al.
Publicado: (2005)

The flagellin/Toll-like receptor 5 axis elicits diffuse proinflammatory signaling and innate immune defenses in vivo
por: Rolli, Joelle, et al.
Publicado: (2008)

Benzisothiazole derivative inhibits toll-like receptor 4 signal transduction and prevents mice from the lethal shock
por: Hosaka, Y, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_bopb88iv6e4s4flj0a32bilk9c